US$ 27.97
glp-1 agonists for type 2 diabetes receptor and beyond. Part 1: benefits in GLP-1 agonists and changes in
Description
Rouette, J

Among lean tissues, loss of liver mass exceeds change in muscle mass
[cited 2025 Feb 1]

Diabetes Care (2015) 38(2):26470

Scientia Pharmaceutica 93 (2)

The plaintiffs hope to uncover information to support their legal claims against Eli Lilly and other pharmaceutical corporations
